DWTX vs GIS · $8.2M cap vs P/E 8.2, rev $4.61B
Dogwood Therapeutics, Inc. (DWTX) versus General Mills Inc (GIS) — a side-by-side from cached financials, not a winner call.
Dogwood Therapeutics, Inc. (DWTX) is a biotechnology company listed on US.
General Mills Inc (GIS) is a packaged foods company listed on NYSE.
DWTX does not have a complete income-statement cache yet.
Latest reported GIS revenue for 2026-05-31 was $4.61B. Net income was -$2.01B. Revenue was up 1.2% from 2025-05-25 to 2026-05-31. GIS currently screens at market cap $17.80B and trailing P/E 8.2.
DWTX currently screens at market cap $8.2M. GIS currently screens at market cap $17.80B and trailing P/E 8.2.
Not investment advice. Open the DWTX and GIS stock pages for the full models.
Not investment advice.